BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28825058)

  • 1. Recent advances in modelling of cerebellar ataxia using induced pluripotent stem cells.
    Wong MMK; Watson LM; Becker EBE
    J Neurol Neuromedicine; 2017 Jul; 2(7):11-15. PubMed ID: 28825058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.
    Watson LM; Wong MM; Becker EB
    Open Biol; 2015 Jul; 5(7):150056. PubMed ID: 26136256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells.
    Watson LM; Wong MMK; Vowles J; Cowley SA; Becker EBE
    Cerebellum; 2018 Aug; 17(4):419-427. PubMed ID: 29397531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Review: Investigating ARSACS: models for understanding cerebellar degeneration.
    Artero Castro A; Machuca C; Rodriguez Jimenez FJ; Jendelova P; Erceg S
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):531-537. PubMed ID: 30636067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
    Kasumu A; Bezprozvanny I
    Cerebellum; 2012 Sep; 11(3):630-9. PubMed ID: 20480274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias.
    Hommersom MP; Buijsen RAM; van Roon-Mom WMC; van de Warrenburg BPC; van Bokhoven H
    Stem Cell Rev Rep; 2022 Feb; 18(2):441-456. PubMed ID: 34031815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hiPSC Disease Modeling of Rare Hereditary Cerebellar Ataxias: Opportunities and Future Challenges.
    Lukovic D; Moreno-Manzano V; Rodriguez-Jimenez FJ; Vilches A; Sykova E; Jendelova P; Stojkovic M; Erceg S
    Neuroscientist; 2017 Oct; 23(5):554-566. PubMed ID: 28281409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.
    Hadjivassiliou M
    CNS Neurol Disord Drug Targets; 2019; 18(6):423-431. PubMed ID: 29268693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Disease Modeling with Patient-Derived iPSCs.
    Muguruma K
    Cerebellum; 2018 Feb; 17(1):37-41. PubMed ID: 29196977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining cerebellar ataxia in degenerative ataxias: lessons from recent research on cerebellar systems.
    Tada M; Nishizawa M; Onodera O
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):922-8. PubMed ID: 25637456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using human induced pluripotent stem cells to model cerebellar disease: hope and hype.
    Wiethoff S; Arber C; Li A; Wray S; Houlden H; Patani R
    J Neurogenet; 2015; 29(2-3):95-102. PubMed ID: 25985846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebellar ataxia and functional genomics: Identifying the routes to cerebellar neurodegeneration.
    Smeets CJ; Verbeek DS
    Biochim Biophys Acta; 2014 Oct; 1842(10):2030-2038. PubMed ID: 24726947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exploration of preventive drugs for spinocerebellar ataxia using cultured cerebellar Purkinje cells].
    Seki T
    Nihon Yakurigaku Zasshi; 2019; 154(6):310-314. PubMed ID: 31787682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models of human cerebellar ataxias: a cornerstone for the therapies of the twenty-first century.
    Manto M; Marmolino D
    Cerebellum; 2009 Sep; 8(3):137-54. PubMed ID: 19669387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar ataxias.
    Manto M; Marmolino D
    Curr Opin Neurol; 2009 Aug; 22(4):419-29. PubMed ID: 19421057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated acquired ataxias.
    Hadjivassiliou M
    Handb Clin Neurol; 2012; 103():189-99. PubMed ID: 21827889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).
    Prestori F; Moccia F; D'Angelo E
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
    Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H
    J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ion channel dysfunction in cerebellar ataxia.
    Bushart DD; Shakkottai VG
    Neurosci Lett; 2019 Jan; 688():41-48. PubMed ID: 29421541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological Disease Modelling for Spinocerebellar Ataxia Using Zebrafish.
    Namikawa K; Dorigo A; Köster RW
    J Exp Neurosci; 2019; 13():1179069519880515. PubMed ID: 31666796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.